This delivery method ensures 100% bioavailability, bypassing the digestive system for maximum absorption
Thousands allege they developed severe, sometimes permanent stomach dysfunction altering their ability to eat, work, and live normally
This product is a food ingredient, not intended to diagnose, treat, cure, or prevent any disease, and is not a weight-loss product or a substitute for GLP-1 medication
As part of a comprehensive approach, GLP-1 obesity management medications help combat these biological drivers
Ros shipping timeline varies by medication source: brand-name products via NovoCare or LillyDirect may follow those manufacturers shipping cadence, while compounded and other pharmacy-fulfilled medications follow Ros partner pharmacy timelines
Overall survival (OS) was 94.1% at 36 months and 87.3% at 60 months